Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China

Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been we...

Full description

Saved in:
Bibliographic Details
Published inJournal of atherosclerosis and thrombosis
Main Authors Yang, Ping-Ting, Tang, Li, Guo, Hui-Rong, He, Yong-Mei, Qin, Yue-Xiang, Yan, Lei, Li, Zhen-Xin, Guo, Ya-Zhang, Wang, Jian-Gang
Format Journal Article
LanguageEnglish
Published Japan 22.10.2024
Subjects
Carotid intima-media thickness (cIMT)
Testing rate
Lipoprotein(a)
Atherosclerosis
Brachial-ankle pulse wave velocity (baPWV)
Online AccessGet full text

Cover

Abstract Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been well studied. A cross-sectional study was conducted using a random sample of 30,000 medical examiners from each of the five health check-up centres. The distribution of Lp(a) was described for those who completed Lp(a) testing, and logistic regression modelling was used to evaluate the relationship between Lp(a) levels and vascular structure and function in the population who underwent carotid ultrasound and brachial‒ankle pulse wave velocity (baPWV) measurements. Lp(a) was measured in only 4400 (3.02%) of the 150,000 participants. Among those tested for Lp(a), the median concentration was 15.85 mg/dL. The proportion of participants with Lp(a) levels ≥ 30 mg/dL was 15.00%. Multiple logistic regression analysis revealed a significant correlation between Lp(a) and cIMT ≥ 1.0 mm (OR: 1.008, 95% CI: 1.001-1.014, P=0.020) and carotid artery plaques (OR: 1.010, 95% CI: 1.004-1.016, P=0.001) but no correlation with baPWV ≥ 1400 (OR: 0.999, 95% CI: 0.993-1.005, P=0.788) or baPWV ≥ 1800 (OR: 1.002, 95% CI: 0.993-1.011, P=0.634). The detection rate of Lp(a) at health checkups is low, and Lp(a) is positively associated with cervical vascular sclerosis and plaque but not with baPWV. Therefore, the testing rate of Lp(a) and the awareness of the risk of vascular structural changes due to Lp(a) should be further improved.
AbstractList Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been well studied.AIMSLipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been well studied.A cross-sectional study was conducted using a random sample of 30,000 medical examiners from each of the five health check-up centres. The distribution of Lp(a) was described for those who completed Lp(a) testing, and logistic regression modelling was used to evaluate the relationship between Lp(a) levels and vascular structure and function in the population who underwent carotid ultrasound and brachial‒ankle pulse wave velocity (baPWV) measurements.METHODSA cross-sectional study was conducted using a random sample of 30,000 medical examiners from each of the five health check-up centres. The distribution of Lp(a) was described for those who completed Lp(a) testing, and logistic regression modelling was used to evaluate the relationship between Lp(a) levels and vascular structure and function in the population who underwent carotid ultrasound and brachial‒ankle pulse wave velocity (baPWV) measurements.Lp(a) was measured in only 4400 (3.02%) of the 150,000 participants. Among those tested for Lp(a), the median concentration was 15.85 mg/dL. The proportion of participants with Lp(a) levels ≥ 30 mg/dL was 15.00%. Multiple logistic regression analysis revealed a significant correlation between Lp(a) and cIMT ≥ 1.0 mm (OR: 1.008, 95% CI: 1.001-1.014, P=0.020) and carotid artery plaques (OR: 1.010, 95% CI: 1.004-1.016, P=0.001) but no correlation with baPWV ≥ 1400 (OR: 0.999, 95% CI: 0.993-1.005, P=0.788) or baPWV ≥ 1800 (OR: 1.002, 95% CI: 0.993-1.011, P=0.634).RESULTSLp(a) was measured in only 4400 (3.02%) of the 150,000 participants. Among those tested for Lp(a), the median concentration was 15.85 mg/dL. The proportion of participants with Lp(a) levels ≥ 30 mg/dL was 15.00%. Multiple logistic regression analysis revealed a significant correlation between Lp(a) and cIMT ≥ 1.0 mm (OR: 1.008, 95% CI: 1.001-1.014, P=0.020) and carotid artery plaques (OR: 1.010, 95% CI: 1.004-1.016, P=0.001) but no correlation with baPWV ≥ 1400 (OR: 0.999, 95% CI: 0.993-1.005, P=0.788) or baPWV ≥ 1800 (OR: 1.002, 95% CI: 0.993-1.011, P=0.634).The detection rate of Lp(a) at health checkups is low, and Lp(a) is positively associated with cervical vascular sclerosis and plaque but not with baPWV. Therefore, the testing rate of Lp(a) and the awareness of the risk of vascular structural changes due to Lp(a) should be further improved.CONCLUSIONSThe detection rate of Lp(a) at health checkups is low, and Lp(a) is positively associated with cervical vascular sclerosis and plaque but not with baPWV. Therefore, the testing rate of Lp(a) and the awareness of the risk of vascular structural changes due to Lp(a) should be further improved.
Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although guidelines and consensuses in various cardiovascular fields have emphasized the importance of Lp(a), screening for Lp(a) in China has not been well studied. A cross-sectional study was conducted using a random sample of 30,000 medical examiners from each of the five health check-up centres. The distribution of Lp(a) was described for those who completed Lp(a) testing, and logistic regression modelling was used to evaluate the relationship between Lp(a) levels and vascular structure and function in the population who underwent carotid ultrasound and brachial‒ankle pulse wave velocity (baPWV) measurements. Lp(a) was measured in only 4400 (3.02%) of the 150,000 participants. Among those tested for Lp(a), the median concentration was 15.85 mg/dL. The proportion of participants with Lp(a) levels ≥ 30 mg/dL was 15.00%. Multiple logistic regression analysis revealed a significant correlation between Lp(a) and cIMT ≥ 1.0 mm (OR: 1.008, 95% CI: 1.001-1.014, P=0.020) and carotid artery plaques (OR: 1.010, 95% CI: 1.004-1.016, P=0.001) but no correlation with baPWV ≥ 1400 (OR: 0.999, 95% CI: 0.993-1.005, P=0.788) or baPWV ≥ 1800 (OR: 1.002, 95% CI: 0.993-1.011, P=0.634). The detection rate of Lp(a) at health checkups is low, and Lp(a) is positively associated with cervical vascular sclerosis and plaque but not with baPWV. Therefore, the testing rate of Lp(a) and the awareness of the risk of vascular structural changes due to Lp(a) should be further improved.
ArticleNumber 65214
Author Yang, Ping-Ting
Qin, Yue-Xiang
Tang, Li
Yan, Lei
Wang, Jian-Gang
He, Yong-Mei
Guo, Hui-Rong
Li, Zhen-Xin
Guo, Ya-Zhang
Author_xml – sequence: 1
  givenname: Ping-Ting
  surname: Yang
  fullname: Yang, Ping-Ting
  organization: Health Management Medical Center, The Third Xiangya Hospital, Central South University
– sequence: 2
  givenname: Li
  surname: Tang
  fullname: Tang, Li
  organization: Shaoxing Second Hospital
– sequence: 3
  givenname: Hui-Rong
  surname: Guo
  fullname: Guo, Hui-Rong
  organization: Health Management Center, Changji Branch of The First Affiliated Hospital, Xinjiang Medical University
– sequence: 4
  givenname: Yong-Mei
  surname: He
  fullname: He, Yong-Mei
  organization: Department of Health Management, Aerospace Center Hospital
– sequence: 5
  givenname: Yue-Xiang
  surname: Qin
  fullname: Qin, Yue-Xiang
  organization: Health Management Medical Center, The Third Xiangya Hospital, Central South University
– sequence: 6
  givenname: Lei
  surname: Yan
  fullname: Yan, Lei
  organization: Department of General Practice, The Third Xiangya Hospital, Central South University
– sequence: 7
  givenname: Zhen-Xin
  surname: Li
  fullname: Li, Zhen-Xin
  organization: Xiangya School of Medicine, Central South University
– sequence: 8
  givenname: Ya-Zhang
  surname: Guo
  fullname: Guo, Ya-Zhang
  organization: Health Management Center, First Affiliated Hospital of Jishou University
– sequence: 9
  givenname: Jian-Gang
  surname: Wang
  fullname: Wang, Jian-Gang
  organization: Health Management Medical Center, The Third Xiangya Hospital, Central South University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39443133$$D View this record in MEDLINE/PubMed
BookMark eNo9kEtPAyEUhYmpsb4W_gHDsi6qMEBhlk3jK6nRhfsJhTspzQxUYDT-e7Gtrs65uV9Ocs4ZGvngAaErSm6FEPRuo_PtTFSUH6FTqhSZMiXZqHjGi-dSjdFZShtCGBOiOkFjVnPOKGOn6OstwqfuwBvAocVLtw3bGDI4P9E3-AV0GiL04DPW3mKXE56nFIzT2QWPv1xe43nMEF1IpoMYkkvY-QJ999sc-oIZ_Oyt-3R20N3ut1g7ry_QcVtuuDzoOXp_uH9fPE2Xr4_Pi_lyamrCpoZbVgvFbG2lJFLomgJpQZpZJSRVMw6cKiHqlVbWcMJNaxktamWt7Wql2Tma7GNLqY8BUm56lwx0nfYQhtQwWhEiZMVVQW_2qCktUoS22UbX6_jdUNL8ztyUmZvdzIW9PsQOqx7sP_m3K_sB-i97fg
Cites_doi 10.1373/clinchem.2010.146779
10.1016/j.amjcard.2018.12.013
10.1161/CIRCULATIONAHA.118.037184
10.1055/a-1340-2109
10.1046/j.1538-7836.2003.00064.x
10.1177/0003319716688415
10.1161/01.ATV.19.4.990
10.1016/j.atherosclerosis.2022.04.005
10.15829/1560-4071-2020-3826
10.1016/j.pcad.2023.07.006
10.1016/j.atherosclerosis.2023.03.007
10.1007/s00380-012-0265-2
10.1016/j.jacc.2019.12.039
10.1016/j.jacc.2021.04.103
10.1161/CIRCGENETICS.113.000400
10.1016/j.hlc.2018.05.190
10.1136/postgradmedj-2019-136591
10.1001/jama.2009.1063
10.1016/j.cca.2006.05.018
10.1161/JAHA.118.008701
10.1016/j.jacc.2021.10.044
10.1093/eurjpc/zwab016
10.1007/s12020-020-02286-5
10.1186/s12944-021-01482-0
10.1111/eci.13689
10.1161/JAHA.119.014581
10.1016/j.jacc.2013.09.038
10.1111/eci.14168
10.1016/j.atherosclerosis.2022.04.006
10.1016/j.atherosclerosis.2021.06.004
10.1093/eurheartj/ehac361
10.1016/j.atherosclerosis.2023.01.014
10.1186/s12872-021-02038-x
10.1097/CP9.0000000000000036
10.1161/HYPERTENSIONAHA.118.11554
10.1161/ATVBAHA.118.312267
10.1093/eurheartj/ehq386
10.1016/j.jacl.2023.09.009
10.1016/j.jacl.2023.09.016
10.1016/j.jacc.2016.11.042
10.1161/ATVBAHA.120.315291
10.1186/s12933-017-0520-z
10.1016/j.cjca.2021.03.016
10.1161/JAHA.120.018023
10.1194/jlr.P049015
10.3389/fcvm.2022.899841
ContentType Journal Article
DBID NPM
AAYXX
CITATION
7X8
DOI 10.5551/jat.65214
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1880-3873
ExternalDocumentID 10_5551_jat_65214
39443133
Genre Journal Article
GroupedDBID ---
.55
29J
2WC
53G
5GY
5VS
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DIK
DU5
E3Z
F5P
GROUPED_DOAJ
GX1
HYE
JMI
JSF
JSH
KQ8
M~E
NPM
OK1
P6G
RJT
RNS
RPM
RZJ
TR2
X7M
3O-
AAYXX
CITATION
TKC
7X8
ID FETCH-LOGICAL-c903-c4d39583d9d77075a91e0fe7c62571864e418559ba8dc404cfd31404d79adbba3
ISSN 1340-3478
1880-3873
IngestDate Thu Oct 24 17:10:30 EDT 2024
Wed Oct 30 12:30:42 EDT 2024
Sat Nov 02 12:27:17 EDT 2024
IsPeerReviewed false
IsScholarly true
Keywords Carotid intima-media thickness (cIMT)
Testing rate
Lipoprotein(a)
Atherosclerosis
Brachial-ankle pulse wave velocity (baPWV)
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c903-c4d39583d9d77075a91e0fe7c62571864e418559ba8dc404cfd31404d79adbba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 39443133
PQID 3120057248
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3120057248
crossref_primary_10_5551_jat_65214
pubmed_primary_39443133
PublicationCentury 2000
PublicationDate 2024-Oct-22
PublicationDateYYYYMMDD 2024-10-22
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-Oct-22
  day: 22
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of atherosclerosis and thrombosis
PublicationTitleAlternate J Atheroscler Thromb
PublicationYear 2024
References 44
45
46
47
48
49
50
51
52
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
References_xml – ident: 26
  doi: 10.1373/clinchem.2010.146779
– ident: 40
  doi: 10.1016/j.amjcard.2018.12.013
– ident: 6
  doi: 10.1161/CIRCULATIONAHA.118.037184
– ident: 31
  doi: 10.1055/a-1340-2109
– ident: 38
  doi: 10.1046/j.1538-7836.2003.00064.x
– ident: 13
  doi: 10.1177/0003319716688415
– ident: 37
  doi: 10.1161/01.ATV.19.4.990
– ident: 24
  doi: 10.1016/j.atherosclerosis.2022.04.005
– ident: 21
  doi: 10.15829/1560-4071-2020-3826
– ident: 14
  doi: 10.1016/j.pcad.2023.07.006
– ident: 36
  doi: 10.1016/j.atherosclerosis.2023.03.007
– ident: 46
  doi: 10.1007/s00380-012-0265-2
– ident: 17
  doi: 10.1016/j.jacc.2019.12.039
– ident: 51
  doi: 10.1016/j.jacc.2021.04.103
– ident: 50
– ident: 5
  doi: 10.1161/CIRCGENETICS.113.000400
– ident: 43
  doi: 10.1016/j.hlc.2018.05.190
– ident: 32
  doi: 10.1136/postgradmedj-2019-136591
– ident: 2
  doi: 10.1001/jama.2009.1063
– ident: 47
  doi: 10.1016/j.cca.2006.05.018
– ident: 16
  doi: 10.1161/JAHA.118.008701
– ident: 44
  doi: 10.1016/j.jacc.2021.10.044
– ident: 8
– ident: 30
  doi: 10.1093/eurjpc/zwab016
– ident: 28
  doi: 10.1007/s12020-020-02286-5
– ident: 34
  doi: 10.1186/s12944-021-01482-0
– ident: 35
  doi: 10.1111/eci.13689
– ident: 33
  doi: 10.1161/JAHA.119.014581
– ident: 4
  doi: 10.1016/j.jacc.2013.09.038
– ident: 49
  doi: 10.1111/eci.14168
– ident: 25
  doi: 10.1016/j.atherosclerosis.2022.04.006
– ident: 41
  doi: 10.1016/j.atherosclerosis.2021.06.004
– ident: 10
  doi: 10.1093/eurheartj/ehac361
– ident: 22
  doi: 10.1016/j.atherosclerosis.2023.01.014
– ident: 42
  doi: 10.1186/s12872-021-02038-x
– ident: 3
  doi: 10.1097/CP9.0000000000000036
– ident: 18
  doi: 10.1161/HYPERTENSIONAHA.118.11554
– ident: 20
– ident: 39
  doi: 10.1161/ATVBAHA.118.312267
– ident: 7
  doi: 10.1093/eurheartj/ehq386
– ident: 23
  doi: 10.1016/j.jacl.2023.09.009
– ident: 11
– ident: 12
  doi: 10.1016/j.jacl.2023.09.016
– ident: 52
  doi: 10.1016/j.jacc.2016.11.042
– ident: 19
– ident: 1
  doi: 10.1161/ATVBAHA.120.315291
– ident: 15
– ident: 27
  doi: 10.1186/s12933-017-0520-z
– ident: 9
  doi: 10.1016/j.cjca.2021.03.016
– ident: 45
  doi: 10.1161/JAHA.120.018023
– ident: 29
  doi: 10.1194/jlr.P049015
– ident: 48
  doi: 10.3389/fcvm.2022.899841
SSID ssj0033552
Score 2.432719
Snippet Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), and its level is genetically determined. Although...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
Title Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China
URI https://www.ncbi.nlm.nih.gov/pubmed/39443133
https://www.proquest.com/docview/3120057248
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkVZ7Qby3vGQQBzi4JLHzOlZol4IoQqhI5RT5FSmHJtU2FWJ__c7YzYNVVwIuUWsnjjTfl_F4PDMm5A0vLZjlErRfmGkmeJkwFQWGafj6TADPaLcVs_iazH-Iz6t4NcTpuuySVk315cG8kv9BFdoAV8yS_Qdk-0GhAX4DvnAFhOH6Vxhj_SXpsoacq7_aNK7sAq71M4nr_cXgAex3CUaAeC_sDKM6q2YLg8OUWbkA2dn293rTNr6e66c-acv19UduHzBqnT05GsrHZ140a4V_exWzd1J_g3mTLbvJ0_kPfMeXqo8L2jlf7nxXse_NcOPc-WF_Qgtb2GrsuogE6nyfhTy1Xt2C9sDqvvyQMo_BmHOHCLTTBIwMMb4HcNisHaqY2MtDX0zjWuXsrus2uROBGsKAv4-rPgCIg6UV-VpT-Kb3_XtOyHH35J_Gyg0rEGeJLO-Ru3tp05nnw31yy9YPyPFiHyTxkPwaaEGbko5o8Va-oyNKUECHAiXoiBIUKUGvU4JWNR1Tgo4ogX2OEo_I8vxs-WHO9udrMJ0HnGlheB5n3OQmTcFylHlog9KmGpbEYLEkwmJhozhXMjNaBEKXhmMxJpPm0igl-WNyVDe1PSVUWxGrUCply0RoJXOjTAbfeqrw-ICIT8jrTo7FxldRKWD1iXIvQO6Fk_uEvOokXICOw40rWdtmty14iL7PNBLZhDzxou-H6aB6emPPM3IykO85OWovdvYFWJKteukIcQWoq3j7
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Lipoprotein%28a%29+Measurement+and+its+Association+with+Arteriosclerosis+in+Asymptomatic+Individuals+in+China&rft.jtitle=Journal+of+atherosclerosis+and+thrombosis&rft.au=Yang%2C+Ping-Ting&rft.au=Tang%2C+Li&rft.au=Guo%2C+Hui-Rong&rft.au=He%2C+Yong-Mei&rft.date=2024-10-22&rft.eissn=1880-3873&rft_id=info:doi/10.5551%2Fjat.65214&rft_id=info%3Apmid%2F39443133&rft.externalDocID=39443133
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1340-3478&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1340-3478&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1340-3478&client=summon